Hiroyuki Nakamura, MD, PhD
- 2Articles
- 31.5KReads1
- 2017–2019Active
- 22Collaborators
- 161Citations2
About
Hiroyuki Nakamura, MD, PhD, has published research focused on the prevention of delirium, particularly examining the use of ramelteon and suvorexant in patients at risk. Nakamura's work includes clinical trials assessing the effectiveness of these pharmacological interventions within the field of neurology. The author has contributed to the literature between 2017 and 2019, collaborating frequently with Akiko Kurata, Chie Usui, Ken Wada, Kotaro Hatta, and Shigeo Ito.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
